{"id":"W4286294933","doi":"10.1200/jco.2022.40.16_suppl.2042","title":"A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Izaak Walton Killam Health Centre; Alberta Children's Hospital; McGill University Health Centre; Centre Hospitalier Universitaire de Sherbrooke; Université Laval; Hospital for Sick Children; BC Children's Hospital; University of Toronto; SickKids Foundation; Centre hospitalier de l'Université Laval; Centre Hospitalier Universitaire Sainte-Justine","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Neurofibromatosis; Trametinib; Dysgeusia; Internal medicine; Gastroenterology; Progressive disease; Refractory (planetary science); Glioma; Surgery; Adverse effect; MAPK/ERK pathway; Oncology; Pathology; Disease; Cancer research","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001410257,0.001509409,0.001552137,0.0003965888,0.0003212521,0.0007289193,0.0007389639,0.001084099,0.002979477],"category_scores_gemma":[0.0007631498,0.0004805679,0.0009808153,0.0004184654,0.0005420261,0.0007265952,0.0002969104,0.002027058,0.0007863321],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001024566,"about_ca_system_score_gemma":0.00178666,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001349539,"about_ca_topic_score_gemma":0.00330284,"domain_scores_codex":[0.9996568,0.0001577254,0.00001612858,0.00005340376,0.0000331484,0.00008287223],"domain_scores_gemma":[0.9994411,0.00008368762,0.0001164506,0.00003645857,0.00003762443,0.0002847367],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7179394,0.07728746,0.01930357,0.00161788,0.001964731,0.001441509,0.0005787819,0.00376639,0.03465978,0.0004735237,0.009113983,0.1318531],"study_design_scores_gemma":[0.6591635,0.312104,0.01913631,0.00004227207,0.0003737838,0.001233022,0.00007810757,0.00146621,0.002119032,0.0001311744,0.004126159,0.00002635749],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922562,0.001884333,0.0003645767,0.00040323,0.00007715171,0.002505947,0.001230515,0.00005670259,0.001221406],"genre_scores_gemma":[0.9864006,0.002150606,0.001432494,0.0008812568,0.0001510391,0.003664613,0.003394783,0.00002444583,0.00190032],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002979477,"threshold_uncertainty_score":0.009967387,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08662136118785654,"score_gpt":0.433313658576669,"score_spread":0.3466922973888125,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}